Compass Pathways Plc - ADR Stock
$4.58
3.74%
yesterday
Nasdaq,
Nov 25, 09:58 pm CET
Compass Pathways Plc - ADR Stock price
$4.57
-1.71
27.23%
1M
-2.91
38.90%
6M
-4.18
47.77%
YTD
-1.49
24.59%
1Y
-27.47
85.74%
3Y
-12.43
73.12%
5Y
-12.43
73.12%
10Y
Nasdaq,
Closing price Mon, Nov 25 2024
+0.16
3.63%
Powered by
Key metrics
| Market capitalization | $312.68m |
| Enterprise Value | $137.89m |
| P/E (TTM) P/E ratio | negative |
| EV/FCF (TTM) EV/FCF | negative |
| P/B ratio (TTM) P/B ratio | 1.62 |
| Revenue (TTM) Revenue | $0.00 |
| EBIT (operating result TTM) EBIT | $-169.05m |
| Free Cash Flow (TTM) Free Cash Flow | $-105.63m |
| Cash position | $207.34m |
Show more
Is Compass Pathways Plc - ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.
Compass Pathways Plc - ADR Stock Analysis
Unlock Scores for Free
Analyst Opinions
11 Analysts have issued a Compass Pathways Plc - ADR forecast:
Analyst Opinions
11 Analysts have issued a Compass Pathways Plc - ADR forecast:
Buy
100%
Financial data from Compass Pathways Plc - ADR
| Sep '24 |
+/-
%
|
||
| Revenue | - - |
-
|
|
| Gross Profit | - - |
-
|
|
| EBITDA | -170 -170 |
32%
32%
|
EBIT (Operating Income) EBIT | -169 -169 |
29%
29%
|
| Net Profit | -145 -145 |
24%
24%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about Compass Pathways Plc - ADR directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Compass Pathways Plc - ADR Stock News
Neutral
Business Wire
●
about 15 hours ago
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that members of the executive management team will participate in the following investor conferences in addition to hosting investor meetings: 7th Annual Evercore ISI HealthCONx...
Neutral
GlobeNewsWire
●
12 days ago
LONDON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will present at the Stifel 2024 Healthcare Conference at 10:55 am ET on November 19, 2024.
Positive
Proactive Investors
●
14 days ago
President-elect Donald Trump's promise that Robert F Kennedy Junior (RFK Jr) will take on a “big role” in shaping health policy could be a positive for psychedelics given RKF Jr's well-documented support of this drug class, analysts at Jefferies believe. “RFK Jr seems positively inclined and sounds motivated to help foster psychedelic drug development,” analysts wrote in a note to clients, noti...
Company Profile
| Head office | United Kingdom |
| CEO | Kabir Nath |
| Employees | 186 |
| Founded | 2016 |
| Website | compasspathways.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
